AR and prostate carcinoma: For example, histone methyltransferase EZH2, a core unit of PRC2 complex, can play a PRC2-independent role by interacting with androgen receptor (AR) to activate a subset of its target genes in an androgen-independent prostate cancer cell line [6] (Fig. 1a).